Increased VEGF165 expression in HCT116 colon cancer cells after transient transfection with a GFP vector encoding HIF-1 gene

Journal of Experimental and Clinical Cancer Research

Volumn 26, Issue 4, 2007, Pages 515-519

  Lucarini, Guendalina ^a   Zizzi, A ^a   Belvederesi, L ^a   Kyriakidou, K ^a   Mazzucchelli, R ^a   Biagini, G ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Gene therapy; GFP vector transfection; HCT116 cells; HIF 1 ; Hypoxia; VEGF

Indexed keywords

BIOLOGICAL MARKER; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN 165;

ANGIOGENESIS; ARTICLE; CANCER CELL; CELL STRAIN HCT116; CLONING VECTOR; COLON CANCER; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; TRANSIENT TRANSFECTION;

COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HCT116 CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38549145393     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mayer P.A., Campbell L., Ricci M.S., Plastaras J.P., Dicker D.T., El-Deiry W.S.: Modulation of TRIAL-induced tumor cell apoptosis in a hypoxic environment. Cancer Biol. Ther. 4:1068-74, 2005.
2. Yang Q.C., Zeng B.F., Shi Z.M., Dong Y., Jiang Z.M., Huang J., Lv Y.M., Yang C.X., Liu Y.W.: Inhibition of hypoxia-induced angiogenesis by Trichostatin A via suppression of HIF-1α activity in human osteosarcoma. J. Exp. Clin. Cancer Res. 25: 593-599, 2006.
3. Wang G.L., Jiang B.H., Rue E.A., Semenza G.L.: Hypoxia inducible factor 1 is a basic-helix-loop-helix- PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. 92:5510-14, 1995.
4. Gao W., Gao Y., Zhang G., Song L., Sun B., Shi J.Q.: Hypoxia-induced expression of HIF-1? and its target genes in umbilical venous endothelial cells of Tibetans and immigrant Han. Compar. Biochem. Physiol. Toxicol Pharmacol. 141:93-100, 2005.
5. 2 tension. Am. J. Physiol. 271:C1172-80, 1996.
6. Carmeliet P., Dor Y., Herbert J.M., Fukumura D., Brusselmans K., Dewerchin M., Neeman M., Bono F., Abramovitch R., Maxwell P., Koch C.J., Ratcliffe P., Moons L., Jain R.K., Collen D., Keshet E.: Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumor angiogenesis. Nature 394:485-90, 1998.
7. Ma J., Zhang L., Ru G.Q., Zhao Z.S., Xu W.J.: Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma. World Gastroenterol. 13:1680-86, 2007.
8. Zhong H., De Marzo A.M., Laughner E., Lim M., Hilton D.A., Zagzag D., Buechler P., Isaacs W.B., Semenza G.L., Simons J.W.: Overexpression of hypoxia-inducible factor 1 in common human cancers and their metastases. Cancer Res. 59:5830-35, 1999.
9. Ravi R., Mookerjee B., Bhujwalla Z.M., Sutter C.H., Artemov D., Zeng Q., Dillehay L.E., Madan A., Semenza G.L., Bedi A.: Regulation of tumor angiogenesis by p53 induced degradation of hypoxia-inducible factor 1α. Gene Dev. 14:34-44, 2000.
10. Sonna L.A., Culliva L.M., Sheldon H.K., Pratt R.E., Lilly C.M.: Effect of hypoxia on gene expression by human hepatocytes (HepG2). Physiol. Genomics. 12:195-207, 2003.
11. Semenza G.L.: HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8:S62-S67, 2002.
12. Tang N., Wang L., Esko J., Giodano F.J., Huang Y., Gerber H.-P., Ferrara N., Johnson R.S.: Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell. 6:485-495, 2004.
13. Calvani M., Rapisarda A., Uranchimeg B., Shoemaker R.H., Melillo G.: Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells. Blood 107:2705-12, 2005.
14. Semenza G.L.: HIF-1 and human disease: one highly involved factor. Genes & Dev. 14:1983-91, 2000.
15. Kastrup J., Jorgensen E., Drvota V.: Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium. Scand. Cardiovasc. J. 35:291-296, 2001.
16. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., Semenza G.L.: Insulin-like factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signalling in colon cancer cells. J. Biol. Chem. 277:38205-211, 2002.
17. Elder D.J., Baker J.A., Banu N.A., Moorghen M., Paraskeva C.: Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J. Pathol. 198:428-34, 2002.
18. Arnoletti J.P., Upson J., Babb J.S., Bellicosa A., Watson J.C.: Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis. J.Exp.Clin.Cancer Res. 24: 279-287,2005
19. Kaidi A., Qualtrough D., Williams A.C., Paraskeva C.: Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 66:6683-91, 2006.
20. Hewitson K.S., Schofield C.J.: The HIF pathway as a therapeutic target. Drug Discov. Today. 9:704-711, 2004.
21. Trentin D., Hall H., Wechsler S., Hubbell J.A.: Tissue engineering special feature: peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1 (alpha) variant for local induction of angiogenesis. PNAS. 103:2506-11, 2006.
22. Koumenis C., Maxwell P.H.: Low oxygen stimulates the intellect. EMBO Reports 7:679-683, 2006.